Clinical Trial Update: Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase 1/2 trial evaluated belinostat in adults with unresectable or advanced primary liver cancers, including hepatocellular carcinoma, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cancer

Drugs mentioned

• BELEODAQ (BELINOSTAT)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-09-26